Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. SPY
2. FLNC
3. CRM
4. GNRC
5. CRWV
6. NVDA
7. USO
8. LMT
9. AMZN
10. META

Go back to Lineage Provides Update on COR1 Cell Therapy Program for Corneal Endothelial Disease
(NYSE: LCTX) Delayed: 1.03 -0.04 (3.74%)
Previous Close $1.07    52 Week High $ 
Open $1.10    52 Week Low $ 
Day High $1.10    P/E N/A 
Day Low $1.03    EPS $ 
Volume 901,701       

(NYSE: LCTX) Delayed: 1.03 -0.04 (3.74%)
Previous Close $1.07    52 Week High $ 
Open $1.10    52 Week Low $ 
Day High $1.10    P/E N/A 
Day Low $1.03    EPS $ 
Volume 901,701